Science Explorer Interactive view Map
Company · Dallas · United States

Arog Pharmaceuticals (United States)

arogpharma.comROR OpenAlex
Research works
27
▼ 58% vs 2013–17
Citations
766
28.2 per fractional work
Top-10% rate
19.5%
record average 16.5%
Open access
23%
world 28%

Not ranked overall: Arog Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Arog Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Prognostic Factors, Mutation, Cancer Therapy, Therapeutic Targets, Chronic Lymphocytic Leukemia, Genomic Aberrations, Acute Myeloid Leukemia and AML.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Prognostic Factors7▲ 55×5 topics
  2. Mutation3▲ 80×2 topics
  3. Cancer Therapy3▲ 18×6 topics
  4. Therapeutic Targets3▲ 47×3 topics
  5. Chronic Lymphocytic Leukemia3▲ 218×1 topic
  6. Genomic Aberrations3▲ 218×1 topic
  7. AML3▲ 204×1 topic
  8. Acute Myeloid Leukemia3▲ 204×1 topic
  9. Apoptosis2▲ 22×5 topics
  10. BCR-ABL2▲ 288×1 topic
  11. Imatinib2▲ 288×1 topic
  12. Inflammation2▲ 3.4×12 topics
  13. Imatinib Mesylate2▲ 117×2 topics
  14. Regulation2▲ 10×3 topics
  15. Cancer1▲ 3.7×9 topics
  16. Immunotherapy1▲ 7.7×6 topics
  17. Tumor Microenvironment1▲ 15×5 topics
  18. Cell Cycle1▲ 79×2 topics
  19. Clinical Trials1▲ 6.9×3 topics
  20. MDM21▲ 103×1 topic
  21. p531▲ 103×1 topic
  22. Targeted Therapy1▲ 18×3 topics
  23. Cell Death1▲ 19×2 topics
  24. Genomic Profiling1▲ 37×2 topics
  25. PDGFRA Mutations1▲ 128×1 topic
  26. Sunitinib1▲ 128×1 topic

Which research topics does Arog Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: RNA modifications and cancer, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments and Ion Transport and Channel Regulation.

RNA modifications and ca…0RNA modifications and cancer: 0 fractional worksAcute Myeloid Leukemia R…0Acute Myeloid Leukemia Research: 0 fractional worksChronic Myeloid Leukemia Treatments: 0 fractional worksIon Transport and Channe…0Ion Transport and Channel Regulation: 0 fractional worksPotassium and Related Di…0Potassium and Related Disorders: 0 fractional worksChronic Lymphocytic Leuk…0Chronic Lymphocytic Leukemia Research: 0 fractional worksRenal function and acid-…0Renal function and acid-base balance: 0 fractional worksDental Health and Care Utilization: 0 fractional worksOral microbiology and periodontitis research: 0 fractional worksCannabis and Cannabinoid Research: 0 fractional works
Molecular BiologyHematologyPulmonary and Respiratory MedicineGenetics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 RNA modifications and cancer Molecular Biology 0 works
  2. 2 Acute Myeloid Leukemia Research Hematology 0 works
  3. 3 Chronic Myeloid Leukemia Treatments Hematology 0 works
  4. 4 Ion Transport and Channel Regulation Molecular Biology 0 works
  5. 5 Potassium and Related Disorders Pulmonary and Respiratory Medicine 0 works
  6. 6 Chronic Lymphocytic Leukemia Research Genetics 0 works
  7. 7 Renal function and acid-base balance Nephrology 0 works
  8. 8 Dental Health and Care Utilization Periodontics 0 works
  9. 9 Oral microbiology and periodontitis research Periodontics 0 works
  10. 10 Cannabis and Cannabinoid Research Pharmacology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available22.6%not open77.4%

World: 28% of research is openly available.

with international co-authors18.9%domestic only81.1%

World: 19% is written across borders.

How has Arog Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 58% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Dallas

All research institutions in Dallas

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.